ATE454902T1 - Verwendung von shigella invaplex für den transport von funktionalen proteinen und transkriptionsaktiven nukleinsäuren durch säugetier-zellmembranen in vitro und in vivo - Google Patents
Verwendung von shigella invaplex für den transport von funktionalen proteinen und transkriptionsaktiven nukleinsäuren durch säugetier-zellmembranen in vitro und in vivoInfo
- Publication number
- ATE454902T1 ATE454902T1 AT04811761T AT04811761T ATE454902T1 AT E454902 T1 ATE454902 T1 AT E454902T1 AT 04811761 T AT04811761 T AT 04811761T AT 04811761 T AT04811761 T AT 04811761T AT E454902 T1 ATE454902 T1 AT E454902T1
- Authority
- AT
- Austria
- Prior art keywords
- transport
- vivo
- nucleic acids
- invaplex
- cell membranes
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 241000124008 Mammalia Species 0.000 title abstract 2
- 238000000338 in vitro Methods 0.000 title abstract 2
- 108020004707 nucleic acids Proteins 0.000 title abstract 2
- 102000039446 nucleic acids Human genes 0.000 title abstract 2
- 150000007523 nucleic acids Chemical class 0.000 title abstract 2
- 241000607768 Shigella Species 0.000 title 1
- 210000000170 cell membrane Anatomy 0.000 title 1
- -1 DNA and RNA Chemical class 0.000 abstract 2
- 210000003527 eukaryotic cell Anatomy 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 abstract 1
- 241000251468 Actinopterygii Species 0.000 abstract 1
- 208000004429 Bacillary Dysentery Diseases 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 abstract 1
- 108010041986 DNA Vaccines Proteins 0.000 abstract 1
- 229940021995 DNA vaccine Drugs 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 241000238631 Hexapoda Species 0.000 abstract 1
- 241000270322 Lepidosauria Species 0.000 abstract 1
- 206010040550 Shigella infections Diseases 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 229960000074 biopharmaceutical Drugs 0.000 abstract 1
- 229940077731 carbohydrate nutrients Drugs 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 235000014633 carbohydrates Nutrition 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000002158 endotoxin Substances 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 229920006008 lipopolysaccharide Polymers 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 201000005113 shigellosis Diseases 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52463903P | 2003-11-25 | 2003-11-25 | |
| PCT/US2004/039100 WO2005051421A2 (en) | 2003-11-25 | 2004-11-23 | Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE454902T1 true ATE454902T1 (de) | 2010-01-15 |
Family
ID=34632916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04811761T ATE454902T1 (de) | 2003-11-25 | 2004-11-23 | Verwendung von shigella invaplex für den transport von funktionalen proteinen und transkriptionsaktiven nukleinsäuren durch säugetier-zellmembranen in vitro und in vivo |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7632659B2 (de) |
| EP (1) | EP1701737B1 (de) |
| AT (1) | ATE454902T1 (de) |
| AU (1) | AU2004293031B2 (de) |
| CA (1) | CA2548202C (de) |
| DE (1) | DE602004025144D1 (de) |
| WO (1) | WO2005051421A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE454902T1 (de) * | 2003-11-25 | 2010-01-15 | Us Gov Sec Army | Verwendung von shigella invaplex für den transport von funktionalen proteinen und transkriptionsaktiven nukleinsäuren durch säugetier-zellmembranen in vitro und in vivo |
| CN101711165B (zh) * | 2007-03-27 | 2016-02-24 | 以沃尔特里德军事研究所的名义,由美国陆军部部长为代表的美国政府 | 人造侵袭素复合物 |
| US8722348B2 (en) | 2008-05-28 | 2014-05-13 | Wayne State University | Method and composition for a protein transduction technology and its applications |
| KR102113829B1 (ko) | 2013-10-25 | 2020-05-25 | 웨인 스테이트 유니버시티 | 단백질-유도 생체내 세포 재프로그래밍을 통한 세포 전환 방법, 시스템 및 조성물 |
| KR102047502B1 (ko) * | 2016-06-20 | 2019-11-22 | 셀라이온바이오메드 주식회사 | 포타슘 채널 단백질을 이용한 암 진단용 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000018355A2 (en) * | 1998-09-30 | 2000-04-06 | Walter Reed Army Institute Of Research | Use of purified invaplex from gram negative bacteria as a vaccine |
| DE69923996D1 (de) | 1998-10-21 | 2005-04-07 | Univ Kansas Ct For Res Inc | Methode für die herstellung von gereinigtem invasinprotein und seine anwendung |
| DE60218662T2 (de) | 2001-05-18 | 2007-11-08 | Walter Reed Army Institute Of Research | Heterologer schutz, induziert durch immunisierung mit der invaplex-vakzine |
| ATE454902T1 (de) * | 2003-11-25 | 2010-01-15 | Us Gov Sec Army | Verwendung von shigella invaplex für den transport von funktionalen proteinen und transkriptionsaktiven nukleinsäuren durch säugetier-zellmembranen in vitro und in vivo |
-
2004
- 2004-11-23 AT AT04811761T patent/ATE454902T1/de not_active IP Right Cessation
- 2004-11-23 US US10/994,463 patent/US7632659B2/en not_active Expired - Fee Related
- 2004-11-23 DE DE602004025144T patent/DE602004025144D1/de not_active Expired - Lifetime
- 2004-11-23 AU AU2004293031A patent/AU2004293031B2/en not_active Ceased
- 2004-11-23 WO PCT/US2004/039100 patent/WO2005051421A2/en not_active Ceased
- 2004-11-23 EP EP04811761A patent/EP1701737B1/de not_active Expired - Lifetime
- 2004-11-23 CA CA2548202A patent/CA2548202C/en not_active Expired - Fee Related
-
2009
- 2009-09-21 US US12/563,794 patent/US8110354B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005051421A3 (en) | 2005-09-15 |
| CA2548202A1 (en) | 2005-06-09 |
| EP1701737B1 (de) | 2010-01-13 |
| US7632659B2 (en) | 2009-12-15 |
| EP1701737A2 (de) | 2006-09-20 |
| US20100119543A1 (en) | 2010-05-13 |
| AU2004293031A1 (en) | 2005-06-09 |
| US8110354B2 (en) | 2012-02-07 |
| AU2004293031B2 (en) | 2011-03-31 |
| WO2005051421A2 (en) | 2005-06-09 |
| US20050215474A1 (en) | 2005-09-29 |
| CA2548202C (en) | 2013-05-14 |
| DE602004025144D1 (de) | 2010-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sivagnanam et al. | Exploring living multicellular organisms, organs, and tissues using microfluidic systems | |
| Kang et al. | Human liver sinusoid on a chip for hepatitis B virus replication study | |
| Bachand et al. | “Smart dust” biosensors powered by biomolecular motors | |
| WO2007084342A3 (en) | Codon optimi zed il- 15 and il- 15r-alpha genes for expression in mammalian cells | |
| DK1685243T3 (da) | Immortaliserede fuglecellelinjer til virusproduktion | |
| Prosser et al. | Integrated multi-assay culture model for stem cell chondrogenic differentiation | |
| WO2016158417A1 (ja) | 肝代謝物の毛細胆管様構造への蓄積と排泄を促進する肝細胞培養装置、並びに該肝細胞培養装置を用いた胆汁中又は血液中排泄感受性の候補化合物及び該候補化合物の肝代謝物の評価方法 | |
| Almeida et al. | Perfusion and ultrasonication produce a decellularized porcine whole-ovary scaffold with a preserved microarchitecture | |
| CN107831317A (zh) | 犬冠状病毒抗体快速定量检测卡及使用方法 | |
| Hynes et al. | Micropatterning of 3D microenvironments for living biosensor applications | |
| DE60041243D1 (de) | Gebrauchsverfaheren eines neuen lysyloxidase-verwandten proteins | |
| Raibaut et al. | Selectively activatable latent thiol and selenolesters simplify the access to cyclic or branched peptide scaffolds | |
| Krysko et al. | In vitro veritas: from 2D cultures to organ-on-a-chip models to study immunogenic cell death in the tumor microenvironment | |
| CN208224282U (zh) | 犬冠状病毒抗体定量快速检测系统 | |
| DE602004025144D1 (de) | Verwendung von shigella invaplex für den transportven nukleinsäuren durch säugetier-zellmembranen in vitro und in vivo | |
| Niu et al. | An Engineered Protein-Based Building Block (Albumin Methacryloyl) for Fabrication of a 3D In Vitro Cryogel Model | |
| Utsugi et al. | Strategies for post-translational control of protein expression and their applications | |
| CN103411818B (zh) | 一种固定生物大分子的改性载玻片及方法 | |
| Nakazato et al. | Protein delivery to insect epithelial cells in vivo: Potential application to functional molecular analysis of proteins in butterfly wing development | |
| Maschietto et al. | A live mammalian cells electroporation array for on-chip immunofluorescence | |
| Baliga et al. | Electroporation-and Liposome-Mediated Co-Transfection of Single and Multiple Plasmids | |
| Jafari et al. | Rapid discovery of illuminating peptides for instant detection of opioids in blood and body fluids | |
| Arnold et al. | Separation of membrane protein complexes by native LDS-PAGE | |
| JP6099075B2 (ja) | 核内から細胞質へのターゲットmRNAの輸送を促進する方法、タンパク質の発現方法および製造方法、ならびに、それに用いるキット | |
| Cheremkhina et al. | Influence of aerosolization on endothelial cells for efficient cell deposition in biohybrid and regenerative applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |